ARCHIVE

• Mediceo HD to Cut Costs Further
  March 28, 2005

• PRESS SEMINAR
  March 28, 2005

• Bio Science to Advance into China through Tie-up with Choseido
  March 28, 2005

• OTC NEWS IN BRIEF
  March 28, 2005

• Choseido Aims at Sales of \10 Bil. in 2007
  March 28, 2005

• BUSINESS NEWS IN BRIEF
  March 28, 2005

• NEW PRODUCTS
  March 28, 2005

• PMDA to Beef Up Review Team
  March 28, 2005

• Requirements for FY2005 GE Drug Listing Announced
  March 28, 2005

• Semiannual Business Results
  March 21, 2005

• Alesion Dry Syrup, Enbrel, Zione to Be Added to NHI List on March 18
  March 21, 2005

• Gov't-managed Health Insurance Benefits Down 7th Year in a Row in FY2003
  March 21, 2005

• REGULATORY NEWS IN BRIEF
  March 21, 2005

• Monitor
  March 21, 2005

• Early Data Show Significant Antiplatelet Action for Prasugrel: Sankyo
  March 21, 2005

• Novo Nordisk Aims at Yearly Growth of 10%: Mr Eilersen
  March 21, 2005

• New Study Results on Oral CCR5 Receptor Antagonist Presented: Ono
  March 21, 2005

• BULLETIN
  March 21, 2005

• Seikagaku to Focus on Joint Diseases, Glycosaminoglycans in R&D
  March 21, 2005

• Norvasc Remains No.1 in 4th Qtr: IMS Survey
  March 21, 2005

ページ

• « 先頭
• ‹ Prev
• …
• 475
• 476
• 477
• 478
• 479
• 480
• 481
• 482
• 483
• …
• Next ›
• 最終 »